195 related articles for article (PubMed ID: 27073068)
1. Organotypic slice cultures of human gastric and esophagogastric junction cancer.
Koerfer J; Kallendrusch S; Merz F; Wittekind C; Kubick C; Kassahun WT; Schumacher G; Moebius C; Gaßler N; Schopow N; Geister D; Wiechmann V; Weimann A; Eckmann C; Aigner A; Bechmann I; Lordick F
Cancer Med; 2016 Jul; 5(7):1444-53. PubMed ID: 27073068
[TBL] [Abstract][Full Text] [Related]
2. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
Briasoulis E; Fatouros M; Roukos DH
Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
[No Abstract] [Full Text] [Related]
3. Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response.
Lim CY; Chang JH; Lee WS; Lee KM; Yoon YC; Kim J; Park IY
Pancreatology; 2018 Dec; 18(8):913-927. PubMed ID: 30292644
[TBL] [Abstract][Full Text] [Related]
4. [A case of AFP-producing esophagogastric junction cancer with liver metastases with a good response to chemotherapy].
Nagai Y; Kato T; Harano M; Satoh D; Choda Y; Tokumoto N; Kanazawa T; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M; Ninomiya M; Ohno S
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2349-51. PubMed ID: 25731519
[TBL] [Abstract][Full Text] [Related]
5. Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
Liu X; Jin J; Cai H; Huang H; Zhao G; Zhou Y; Wu J; Du C; Long Z; Fang Y; Ma M; Li G; Zhou M; Yin J; Zhu X; Zhu J; Sheng W; Huang D; Zhu H; Zhang Z; Lu Q; Xie L; Zhang Z; Wang Y
BMC Cancer; 2019 Jun; 19(1):606. PubMed ID: 31221115
[TBL] [Abstract][Full Text] [Related]
6. [A case of adenosquamous carcinoma at the esophagogastric junction, initially diagnosed as collision carcinoma].
Sasaki Y; Harada M; Kurosaki S; Shimada Y; Hayashi M; Kamiichi H; Kawamura N; Kajiyama Y; Yao T
Nihon Shokakibyo Gakkai Zasshi; 2015 May; 112(5):848-55. PubMed ID: 25947020
[TBL] [Abstract][Full Text] [Related]
7. A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).
Kataoka K; Tokunaga M; Mizusawa J; Machida N; Katayama H; Shitara K; Tomita T; Nakamura K; Boku N; Sano T; Terashima M; Sasako M;
Jpn J Clin Oncol; 2015 Nov; 45(11):1082-6. PubMed ID: 26355164
[TBL] [Abstract][Full Text] [Related]
8. Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.
Springfeld C; Wiecha C; Kunzmann R; Heger U; Weichert W; Langer R; Stange A; Blank S; Sisic L; Schmidt T; Lordick F; Jäger D; Grenacher L; Bruckner T; Büchler MW; Ott K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S905-14. PubMed ID: 26001861
[TBL] [Abstract][Full Text] [Related]
9. Irinotecan and cisplatin in advanced gastric or gastroesophageal junction carcinoma.
Ajani JA; Fairweather J; Pisters PW; Charnsangavej C
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):19-21. PubMed ID: 11200143
[TBL] [Abstract][Full Text] [Related]
10. [Long-term survival of a case of advanced cancer of the esophagogastric junction with complete response to low-dose 5-fluorouracil and cisplatin chemotherapy].
Nakashima S; Hatanaka N; Yoshikawa Y; Tominaga H; Sunada S; Shimizu Y; Endo S; Nishitani A; Hiraoka K; Irei T; Takahashi H; Boku M; Wakahara M; Kamiike W; Taniyama K
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1559-61. PubMed ID: 23064072
[TBL] [Abstract][Full Text] [Related]
11. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
12. [A successful resected case of far-advanced cancer at the esophagogastric junction by chemoradiotherapy with docetaxel, nedaplatin and 5-fluorouracil].
Matsutani T; Uchida E; Maruyama H; Suzuki S; Yokoyama T; Matsushita A; Hirakata A; Kawamoto M; Arai H; Umakoshi M; Wakabayashi H; Sasajima K
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1949-52. PubMed ID: 20948262
[TBL] [Abstract][Full Text] [Related]
13. Perioperative Chemotherapy in Elderly Patients with Locally Advanced Adenocarcinoma of the Stomach and the Esophagogastric Junction: A Retrospective Cohort Analysis of Toxicity and Efficacy at the National Center for Tumor Diseases, Heidelberg.
Haag GM; Byl A; Jäger D; Berger AK
Oncology; 2017; 92(5):291-298. PubMed ID: 28249280
[TBL] [Abstract][Full Text] [Related]
14. Treatment of gastric cancer.
Fielding J; Peake D
N Engl J Med; 2006 Sep; 355(13):1386-7; author reply 1387-8. PubMed ID: 17014034
[No Abstract] [Full Text] [Related]
15. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
Reim D; Gertler R; Novotny A; Becker K; zum Büschenfelde CM; Ebert M; Dobritz M; Langer R; Hoefler H; Friess H; Schumacher C
Ann Surg Oncol; 2012 Jul; 19(7):2108-18. PubMed ID: 22130620
[TBL] [Abstract][Full Text] [Related]
16. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
17. [A case of mixed adenoneuroendocrine carcinoma of the esophagogastric junction treated with neoadjuvant chemotherapy].
Nakai M; Kawasaki H; Wajima N; Kimura A; Nakayama Y; Muroya T; Yonaiyama S; Okano K; Nagase H; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2301-3. PubMed ID: 24394092
[TBL] [Abstract][Full Text] [Related]
18. Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal Carcinoma.
Sönnichsen R; Hennig L; Blaschke V; Winter K; Körfer J; Hähnel S; Monecke A; Wittekind C; Jansen-Winkeln B; Thieme R; Gockel I; Grosser K; Weimann A; Kubick C; Wiechmann V; Aigner A; Bechmann I; Lordick F; Kallendrusch S
Clin Colorectal Cancer; 2018 Jun; 17(2):e189-e199. PubMed ID: 29233603
[TBL] [Abstract][Full Text] [Related]
19. The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction Cancer.
Cartwright E; Cunningham D
Curr Treat Options Oncol; 2017 Nov; 18(12):69. PubMed ID: 29143893
[TBL] [Abstract][Full Text] [Related]
20. [A case of advanced adenocarcinoma of esophagogastric junction with severe esophageal invasion effectively treated by chemoradiotherapy using paclitaxel and cisplatin, and S-1 after chemoradiotherapy].
Fujiwara H; Koeda K; Konosu M; Hosoi N; Tamasawa Y; Sase M; Tsukahara T; Ushio A; Taguchi M; Wakabayashi G
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1683-6. PubMed ID: 21996967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
